icd 9 code for nonalcoholic steatohepatitis. The aim of our study was to evaluate the efficacy of the 13C-Octanoate breath test (OBT) as a non-invasive surrogate marker to differentiate patients with NASH from patients with simple steatosis (NAFL). icd 9 code for nonalcoholic steatohepatitis

 
 The aim of our study was to evaluate the efficacy of the 13C-Octanoate breath test (OBT) as a non-invasive surrogate marker to differentiate patients with NASH from patients with simple steatosis (NAFL)icd 9 code for nonalcoholic steatohepatitis  Short description: Chronic liver dis NEC

223. 2014. 0 - other international versions of ICD-10 K74. Background. 69 Nature Medicine (2023) There are no approved diagnostic biomarkers for at-risk non-alcoholic steatohepatitis (NASH), defined by the presence of NASH, high histological activity and fibrosis stage. Nonalcoholic steatohepatitis (NASH) is the inflammatory form of nonalcoholic fatty liver disease (NAFLD). 2 The disease course can lead to advanced fibrosis. Nonalcoholic fatty liver disease (NAFLD) affects one-fourth of the global population and is the most common cause of chronic liver disease. Definition & Facts. 38% in 2021) ( Younossi et al. 2019;101:154005. Overall concordance between clinical documentation and 'grouped alcohol' codes (κ 0. Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F. Background: The diagnosis of NASH needs a liver biopsy, an invasive procedure that is not frequently accepted by patients. Two types of NAFLD are nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Opsi terapi Non-alcoholic Fatty Liver Disease (NAFLD) dan Non-alcoholic Steatohepatitis (NASH) saat ini dapat menggunakan pendekatan farmakologi dan nonfarmakologi. Material and methods: We conducted a. Although a similar. Billable Thru Sept 30/2015. 8. NAFLD was defined using presence of 1 inpatient or 2 outpatient claims using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM), claims codes. 800-544-9144. 8 Chronic liver dis NEC. At present, clinical coding of this diagnosis requires the combination of two imprecise codes: K74. At present, clinical coding of this diagnosis requires the combination of two imprecise codes: K74. Patients with nonalcoholic steatohepatitis (NASH), a subset of NAFLD, are at risk for progressive liver disease and in need of effective treatment options. 81 Nonalcoholic steatohepatitis (NASH) K75. Alcoholic fatty liver. Given the inaccu-racy of administrative coding such as ICD-10, this study most likely underestimates the true incidence of NAFLD. The 2024 edition of ICD-10-CM K76 became effective on October 1, 2023. MS-DRG Mapping . ICD-10: K75. INTRODUCTION. ICD-10-CM Diagnosis Code K71. 0 ‘Fatty (change of) liver, not elsewhere classified (non-alcoholic fatty liver disease)’. ICD-10-CM Code K70. The diagnosis and management of non‐alcoholic fatty liver disease:. 81 - Nonalcoholic steatohepatitis (NASH) answers are found in the ICD-10-CM powered by Unbound Medicine. 9,10 Nonalcoholic steatohepatitis is also fuelingNon-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that affects approximately one-quarter of the global adult population, posing a significant threat to human health with wide-ranging social and economic implications. 9 - other international versions of ICD-10 K70. ICD-10-CM Diagnosis Code K70. It is associated with visceral adiposity and the metabolic syndrome and is nearly as common as type 2 diabetes. Search for: Translate. Nonalcoholic fatty liver disease (NAFLD) will now be metabolic dysfunction-associated steatotic liver disease (MASLD). Non-alcoholic steatohepatitis (NASH) is a condition that falls under the umbrella of non-alcoholic fatty liver diseases (NAFLD), which are caused by fat buildup in the. K75. Clinical background. 2% of non-drinkers and 0. ICD-10-CM Coding Rules. NAFLD/NASH cirrhosis may also attract code K74. 334 obeticholic acid improves experimental non‐invasive markers of non‐alcoholic steatohepatitis and advanced fibrosis; results of a secondary analysis from the month‐18 interim analysis of the REGENERATE study. It is unclear which specific patients progress from NAFL to NASH and, ultimately, to cirrhosis. It is the most common liver disease in the United States. Search online 72,000+ ICD-10 codes by number, disease, injury, drug, or keyword. K75. 0 is a billable /specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2020; 114:104437. About Nonalcoholic steatohepatitis. Overview. ICD-9-CM 571. Fatty replacement and damage to the hepatocytes not related to alcohol use. Nonalcoholic fatty liver disease, or NAFLD, refers to the buildup of excess fat in the liver. 1–0. Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: a propensity matched analysis. 8) is used infrequently in Swedish healthcare, and we did not intend to. 8 should only be used for claims with a date of service on or before September 30, 2015. This is the American ICD-10-CM version of K75. poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4); alcoholic liver disease (K70. It is found in the 2024 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024 . In 2013, NASH became the second leading. Phone: 1–800–891–5389 . The 2024 edition of ICD-10-CM K76 became effective on October 1, 2023. 8: Chronic liver dis NEC: 573. 81 may differ. (2014) USA: Adults receiving liver kidney transplant: Observational cohort study United Network of Organ Sharing (UNOS) database ICD-10-CM Codes. DRGs; HCCs; ICD-11; SNOMED CT; ICD-9-CM;. 2 contain. 0); drug-induced idiosyncratic (unpredictable) liver disease; drug-induced toxic (predictable) liver disease; code for adverse effect, if. Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. 81 is a billable diagnosis code used to specify a medical diagnosis of nonalcoholic steatohepatitis (nash). e. HCC Plus. Perakakis N, Polyzos SA, Yazdani A, et al. 6 : K00-K95. Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis. doi:. NAFLD and NASH can be silent diseases with no symptoms at all or very mild symptoms such as tiredness and fatigue in early stages of the disease. The following code (s) above K70. See full list on my. Billable Thru Sept 30/2015. The 2024 edition of ICD-10-CM K72. How is nonalcoholic steatohepatitis (NASH) treated? Treatment for NASH includes managing conditions that increase your risk for NASH or make it worse. K76 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. 9% and 45. 5, 571. Nonalcoholic steatohepatitis (NASH) This is the more severe form of NAFLD in which you have hepatitis – meaning swelling or inflammation of the liver –– and liver cell damage, in addition to fat in your liver. The 2024 edition of ICD-10-CM K74. Overview Symptoms and Causes Diagnosis and Tests Management and Treatment Prevention Outlook / Prognosis. Showing 1 - 10 of 5853. HCCs; ICD-11 NEW; SNOMED CT NEW; ICD-9-CM;K70. 81) ICD-10-CM Diagnosis Code K74. This is the American ICD-10-CM version of K76. Nonalcoholic fatty liver disease (or NAFLD for short) is a buildup of fat in the liver that is not caused by drinking alcohol. 2011 Jun;54(6):1224-9. Nonalcoholic fatty liver disease. 2014. K75. Davis, MD, MPH 2 ; Sonal Kumar, MD, MPH 3 Author Affiliations Article InformationNAFLD is becoming more common around the world, especially in Middle Eastern and Western nations as the number of people with obesity rises. 22052/12 May 2015). It is the most common form of chronic liver disease, affecting about 25% of the world's population. A new category, outside pure MASLD, termed MetALD (pronunciation: Met A-L-D) was selected to describe those with MASLD who consume greater amounts of alcohol per week (140 g/week and 210 g/week for females and males respectively). 30 [convert to ICD-9-CM] Alcoholic cirrhosis of liver without ascites. et al. Hepatic fibrosis. In one third of patients, the liver is enlarged and smooth, but it is not usually tender. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. Non-invasive tests (Fibrosis-4 (FIB-4) index for liver fibrosis, NAFLD fibrosis score, enhanced liver fibrosis score and. 10 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Nonalcoholic fatty liver disease (NAFLD) is today the most common cause of chronic liver disease and second only to viral hepatitis as a cause of liver transplantation in the U. 40 Chronic hepatitis, unspecified convert 571. Helpline 1-800-465-4837. K75. 24% in 2015 to 29. Nonalcoholic steatohepatitis (NASH) Show additional info Hide additional info. S. 8 ICD-9 Billable. 0000000000001681. 44 Thus, taking a liver biopsy cannot be considered a screening. Recent epidemiologic studies have shown that nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in the US, with an estimated prevalence of 34% in the general population (based on screening using liver proton magnetic resonance spectroscopy). 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis ( NASH) ICD-10-CM Diagnosis Code K74. g. The main treatment option for steatohepatitis is lifestyle modification. Codes . 81, K76. 6 contain annotation back-references that may be applicable to K74. (18–90 year) who had a diagnosis of OSA using the International Classification of Diseases ICD-9 codes. It affects an estimated 20% of the general population, based on cohort studies of varying size and heterogeneous selection. ICD-10-CM Diagnosis Code K70. There are 2 main types of fatty liver disease (FLD): Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). 2174/1381612825666190117102111. To code a diagnosis of this type, you must use one of the two child codes of K70. Excludes2: alcoholic liver disease (K70. 0 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. 00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis. ICD-10-CM Index; ICD-10-CM External Causes Index; Table of Drugs; Table of Neoplasms; Conversion; DRG; Rules . 023. Short description: CHRONIC LIVER DIS NEC. Chronic yellow atrophy (liver) Fatty liver, without mention. Mr T, a 60-year-old man, has obesity, diabetes mellitus, and increased serum transaminase levels. 3 to ICD-10-CM. Healthcare Provider Information about Non-Alcoholic Steatohepatitis (NASH) NASH is a chronic liver disease characterized by liver cell injury (hepatocellular ballooning) and inflammation as a result of fatty accumulation (steatosis) seen in at least 5% of hepatocytes. Non-alcoholic fatty liver disease (NAFLD) — along with its progressive form non-alcoholic steatohepatitis (NASH) — remains the most common chronic liver disease worldwide, affecting around a quarter of the adult population [1, 2]. 9 million patients in 2030 (~1/3. 88) was high. 0) from the Karolinska University Hospital between 1 January 2015 and 3 November 2021 were randomly selected. Chronic yellow atrophy (liver) Fatty liver, without mention. Nonalcoholic steatohepatitis (NASH), the severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma (HCC). An apoptosis panel for nonalcoholic steatohepatitis diagnosis. Inclusion on this list does not serve as official recognition by the NIH that a disease is rare. Nonalcoholic fatty liver disease (NAFLD) ranges from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. BMI indicates body mass index (calculated as weight in kilograms divided by height in meters squared); NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis. To view the entire topic,. ICD-9-CM 571. A NAS of 5 or higher correlates with a diagnosis of NASH whereas a NAS of less than 3 is not consistent with this diagnosis. 3. Fax. K76. 60 - other international versions of ICD-10 K74. Methods: We performed a prospective study on patients with. Applicable To. This is the American ICD-10-CM version of K70. The diagnosis of alcoholic hepatitis is a clinical one with supporting laboratory findings of AH. 0, S0-S3), and. doi: 10. Download references. 1 Even healthy livers contain some fat. 0 - fatty liver degeneration, not classified elsewhere. K74 Fibrosis and cirrhosis of liver. Background Dyslipidemia and non-alcoholic fatty liver disease are well-known diseases and are part of a very broad spectrum evolving toward non-alcoholic steatohepatitis (NASH). 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis ( NASH) ICD-10-CM Diagnosis Code K74. Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD). 2 Alcoholic cirrhosis of liver convert 571. alcoholic liver disease (. The following code (s) above K74. The new codes are as follows:K74. Diagnosis and the follow-up of liver fibrosis, steatosis, and inflammation Estimating hepatic fibrosis Assessing inflammation for metabolic diseases Assessing severity of nonalcoholic steatohepatitis (NASH) in. You may feel tired or have pain in the upper right side of your abdomen, where your liver is. K75 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 81 is VALID for claim submission. NAFLD may progress to cirrhosis and is likely an important cause of cryptogenic cirrhosis [ 1,2 ]. n engl j med 377;21 nejm. 0 is a billable diagnosis code used to specify fatty (change of) liver, not elsewhere classified. 8. Acknowledgements. 5 (Cirrhosis of liver without mention of alcohol), 571. K75. doi: 10. 5, K74. ContentsK75. Liver Transplant Program. The 2024 edition of ICD-10-CM K70. 0. Alcoholic cirrhosis; Alcoholic cirrhosis of liver. Type 2 Excludes. A practical approach. Histological assessment of nonalcoholic fatty liver disease (NAFLD) is essential for clinical practice as it outlines diagnosis and lays the foundation of medical care. The existing literature regarding the relationship between OSA and nonalcoholic steatohepatitis (NASH) is conflicting. Our large population database results emphasize that there is a significant association between OSA and NASH. Includes Excludes I Excludes II Notes From Section K70-K77:. 0) codes in the absence of any diagnosis codes for other common causes of chronic liver disease . 8–571. 6, K74. 650-498-7878. Applicable To. Informed Consent Statement. All patients should have had an abdominal imaging study to exclude biliary obstruction and liver diseases such as hepatocellular carcinoma and liver abscess. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. Lancet Gastroenterol. 571. steatosis with lobular inflammation and hepatocellular ballooning) [Citation 18] were also accepted, but not required, for the ICD-10 code to be considered valid. Save Saved. NASH is defined as ≥5% hepatic steatosis along with hepatocellular injury. Patient Education. Likely NASH patients can be counted in ≥ 1 pattern, possible NASH patients can. ICD-9-CM 571. Afdhal discusses evidence-based management of nonalcoholic fatty liver disease, including differentiation between simple steatosis and nonalcoholic steatohepatitis. Key Results In a prospective study of 132 participants with nonalcoholic steatohepatitis (NASH) who underwent US attenuation imaging and two-dimensional (2D) shear-wave elastography (SWE), the degree of hepatic steatosis was associated with attenuation coefficient and dispersion slope from 2D SWE was associated with the. Quantitative results of 10 biochemicals in combination with age, gender, height, and weight are analyzed using a computational algorithm to provide a quantitative surrogate marker (0. It is found in the 2024 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024 . Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. However, codes underestimated the prevalence of NAFLD/NASH and obesity by 42. Both NAFLD and NASH are characterized by identification of > 5% hepatic steatosis in the absence of excessive alcohol consumption and other etiologies []. K70. Nonalcoholic steatohepatitis (NASH) ICD-10 codes not covered for indications listed in the CPB (not all-inclusive): K74. Nonalcoholic steatohepatitis (NASH) K75. The 2024 edition of ICD-10-CM K75 became effective on October 1, 2023. It is found in the 2024 version of the ICD-10 Clinical. Type 2 Excludes. Test: 550960. [1] There are 2 main types of fatty liver disease (FLD): Metabolic Dysfunction Associated Steatotic. The E-DII. ICD-10-CM Diagnosis Code K75. diseases (non-alcoholic steatohepatitis)’ and K76. 10 may differ. 2012 ICD-9-CM Diagnosis Code 571. The condition is characterised by excessive hepatic fat accumulation and is directly associated with. However, there is general consensus that, for those patients who do progress to cirrhosis (fibrosis stage 4), there is. Nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) are types of NAFLD. Applicable To. 21037/atm-20-4354. NAFLD is a fatty infiltration of the liver and the first pathological step for nonalcoholic steatohepatitis (NASH), a. Take steps toward getting a diagnosis by working with your doctor, finding the right specialists, and coordinating medical care. 1. Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common, currently affecting approximately 37% of US adults. Code Classification: Diseases of the digestive system (K00–K93) Diseases of liver (K70-K77). MRE-based NASH score for diagnosis of. 6 may differ. Doctors use your medical history, a physical exam, and tests to diagnose nonalcoholic fatty liver disease (NAFLD)—including nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). K70. 6. 8 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC; 504960: NASHnext (NIS4) 93692-2: 504964: NIS4 Test: 93692-2: Test Menu Right Side Menu. Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in shrsp5/dmcr rat model. (NAFLD) can be daunting but watch how Shawanna met the challenge head on and is reversing her diagnosis with weight loss, healthy eating and exercise!Since the code for ICD-10 (International Classification of Diseases) does not have a single designation, today the most common encoding is K76. 2024 ICD-10-CM Range K00-K95. Nonalcoholic steatohepatitis (NASH) – K75. This is the American ICD-10-CM version of K75 - other international versions of ICD-10 K75 may differ. Objective: The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) cirrhosis is often underestimated in healthcare and administrative databases that define disease burden using International Classification of Diseases (ICD) codes. 8 is a billable medical code that can be used to. Metabolism. 41. Control diabetes. If the scarring progresses, hepatic fibrosis can become advanced, resulting in. Although having fat in the liver is not normal, by itself it probably does not damage the liver. It often develops due to a metabolic disorder, such as obesity or diabetes, resulting in a toxic buildup of fat in the liver. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. It also removes fat from the blood that has been released by other tissues in the body, for example, by fat cells. Other Codes Used Similar Conditions. Nonalcoholic steatohepatitis (NASH) is a condition that causes inflammation and accumulation of fat and scar tissue in the liver. The Hospital Discharge Abstract Database (DAD) was used to. 81 is a billable diagnosis code used to specify a medical diagnosis of nonalcoholic steatohepatitis (nash). 0. Clinical background. Long Description: Alcoholic fatty liver. Save Saved. x) and insulin resistance (ICD-9 code 277. exclusions. Occasionally there may be. 11 - other international versions of ICD-10 K71. 1 About 35% of patients with NASH develop progressive liver fibrosis. 0-1. 5 (cirrhosis of liver without mention of alcohol). Metabolic dysfunction–associated steatotic liver disease ( MASLD) is the name adopted in 2023 for the condition previously known as non-alcoholic fatty liver disease ( NAFLD ). K70. NASH is a severe form of nonalcoholic fatty liver disease characterized by chronic inflammation and liver cell injury. 0-) ICD-10-CM Diagnosis. ICD-10-CM Diagnosis Code K70. 0 for Fatty (change of) liver, not elsewhere classified is a medical classification as listed by WHO under the range - Diseases of the digestive system . 3 result found: ICD-10-CM Diagnosis Code K75. The 2024 edition of ICD-10-CM K74. The lack of consensus on definitions threatens the comparability and generalizability of. The 2022 edition of ICD-10-CM K75. The name of the type of pathology speaks for itself - nonalcoholic steatohepatitis, that is, the source of. 114, Digestive System, Diagnostic Code 7345. K76. 41 became effective on October 1, 2023. The prevalence of NAFLD is estimated to be as high as 30%. 81 - Nonalcoholic steatohepatitis (NASH) is a topic covered in the ICD-10-CM. Pendekatan nonfarmakologi terdiri atas modifikasi gaya hidupNASH - Nonalcoholic steatohepatitis (442685003); Nonalcoholic steatohepatitis (442685003); Non-alcoholic steatohepatitis (442685003) Definition. Non-alcoholic fatty liver disease (NAFLD) consists of non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). In the United States, the number of NAFLD cases is rapidly expanding, and is expected to reach 100. The aim of our study was to evaluate the efficacy of the 13C-Octanoate breath test (OBT) as a non-invasive surrogate marker to differentiate patients with NASH from patients with simple steatosis (NAFL). K74. Nonalcoholic steatohepatitis (NASH) is a common but underappreciated liver disease. This is the American ICD-10-CM version of K76 - other international versions of ICD-10 K76 may differ. Diseases of the digestive system. The following code (s) above K70. 9 - other international versions of ICD-10 K75. NASH/NAFLD is the most common chronic liver disease. There are two forms of NAFLD: nonalcoholic fatty liver (NAFL. 6), and ≥ 3 counts of nonalcoholic fatty liver (571. 3, V11. 81. K70 Alcoholic liver disease. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver. The control group included the rest of adult individuals without discharge records of NASH. NAFLD has a histologic spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. Zhang Y, Xing J, Liu L, Qiao F, Li J, et al. The main characteristic of NAFLD is considered that the excessive fat is accumulated and. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH)Here, we aimed to validate the administrative code for NAFLD in Sweden. Nonalcoholic fatty liver disease (NAFLD) encompasses the entire spectrum of fatty liver disease in individuals without significant alcohol consumption, including isolated steatosis, steatohepatitis, and cirrhosis. When using code K70. K74. 2273; 100 Years of Cleveland Clinic;. This ICD-10 code translates to more than one ICD-9 code: 571. Inclusion ICD-9 code: In the ICD-9 branch of chronic liver disease (571) we will include 571. Fax: 703–738–49291 Introduction. Alcoholic hepatitis is hepatitis (inflammation of the liver) due to excessive intake of alcohol. Non-Alcoholic Fatty Liver Disease (NAFLD) is currently the most common cause of chronic liver disease worldwide, and its prevalence is increasing globally. With an increasing prevalence of nonalcoholic fatty liver disease (NAFLD) in the United States, estimates suggest that non-alcoholic steatohepatitis, a severe progression of NAFLD characterized by. Steatohepatitis is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. The presence of cirrhosis was determined based on results of imaging or ICD-9 or 10 codes. miRNA is a small non-coding RNA, comprising ≤ 25 nucleotides. NAFLD is a multifaceted disorder, and its spectrum includes steatosis to steatohepatitis, which may evolve to advanced fibrosis and cirrhosis. Steatohepatitis (nonalcoholic) (NASH) - K75. Code First. This topic will review the treatment and prognosis of NAFLD. 85 versus 0. Our aims were to create and validate a noninvasive prediction model for NASH. ICD 9 Codes: 571. Code First.